AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Stein, RS Wolff, SN Greer, JP Flexner, JM Goodman, S Jagasia, M Brandt, SJ Morgan, DS Arrowsmith, E McCurley, TL
Citation: Rs. Stein et al., Age and cytogenetics as predictors of event free survival in patients withacute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy, LEUK LYMPH, 42(5), 2001, pp. 913-922

Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, D Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma, LEUK LYMPH, 41(3-4), 2001, pp. 343-352

Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, DS Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Is total body irradiation a necessary component of preparative therapy forautologous transplantation in non-Hodgkin's lymphoma, LEUK LYMPH, 41(1-2), 2001, pp. 97-103

Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, DS Macon, WR McCurley, TL
Citation: Rs. Stein et al., Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma, LEUK LYMPH, 40(5-6), 2001, pp. 521-528

Authors: Vusirikala, M Wolff, SN Stein, RS Brandt, SJ Morgan, DS Greer, JP Schuening, FG Dummer, JS Goodman, SA
Citation: M. Vusirikala et al., Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis, BONE MAR TR, 28(3), 2001, pp. 265-270

Authors: Ikpeazu, C Davidson, MK Halteman, D Goodman, SA Browning, PJ Brandt, SJ
Citation: C. Ikpeazu et al., Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation, BIOL BLOOD, 6(3A), 2000, pp. 301-308

Authors: Huang, S Brandt, SJ
Citation: S. Huang et Sj. Brandt, mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor, MOL CELL B, 20(6), 2000, pp. 2248-2259

Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, DS Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma, BONE MAR TR, 25(3), 2000, pp. 257-262

Authors: Huang, SM Qiu, Y Shi, YB Xu, ZX Brandt, SJ
Citation: Sm. Huang et al., P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL, EMBO J, 19(24), 2000, pp. 6792-6803

Authors: Huang, SM Qiu, Y Stein, RW Brandt, SJ
Citation: Sm. Huang et al., P300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein, ONCOGENE, 18(35), 1999, pp. 4958-4967

Authors: Tang, T Prasad, KSS Koury, MJ Brandt, SJ
Citation: T. Tang et al., Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts, BIOCHEM J, 343, 1999, pp. 615-620

Authors: Hasty, AH Linton, MF Brandt, SJ Babaev, VR Gleaves, LA Fazio, S
Citation: Ah. Hasty et al., Retroviral gene therapy in ApoE-deficient mice - ApoE expression in the artery wall reduces early foam cell lesion formation, CIRCULATION, 99(19), 1999, pp. 2571-2576
Risultati: 1-12 |